Cordyceps Sunshine Biotech Holdings (RAJAF) Operating Expenses (2022 - 2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Operating Expenses of $164212.0 in Q4 2023, up 114.77% quarter-over-quarter from $76459.0 in Q4 2022, and up 114.77% on a YoY basis from $76459.0 in Q4 2022.

Cordyceps Sunshine Biotech Holdings (RAJAF) Operating Expenses (2022 - 2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Operating Expenses history runs 2 years deep, the most recent figure standing at $164212.0 for Q4 2023.

  • In Q4 2023, Operating Expenses rose 114.77% year-over-year to $164212.0; the TTM figure through Dec 2025 stood at $164212.0 (down 31.77% YoY), while the FY2025 annual figure was $901869.0, down 17.29% from the prior year.
  • Operating Expenses was $164212.0 for Q4 2023 at Cordyceps Sunshine Biotech Holdings, up from $76459.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $164212.0 in Q4 2023 to a low of $76459.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Paranovus Entertainment Technology 75,216.52 Bn 75,216.52 Bn - -
2 Kraft Heinz 26.76 Bn 22.68 Bn 2.22 Bn 1.07 Bn
3 General Mills 17.79 Bn 17.02 Bn 1.37 Bn 837.30 Mn
4 Jbs 13.93 Bn 9.37 Bn 2.32 Bn -1.84 Bn
5 Hormel Foods 13.00 Bn 12.16 Bn 518.51 Mn 318.62 Mn
6 Mccormick 12.70 Bn 13.10 Bn 708.90 Mn 456.30 Mn
7 Magnum Ice Cream 12.17 Bn 11.70 Bn - -
8 J M Smucker 11.05 Bn 10.99 Bn 827.80 Mn 368.20 Mn
9 Smithfield Foods 10.57 Bn 9.49 Bn 511.00 Mn 180.00 Mn
10 Cordyceps Sunshine Biotech Holdings - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 164,212.00
Dec 31, 2022 76,459.00